New and Revised Pharmacy and Medical Coverage Policies Available

Humana's medical and pharmacy coverage policies are based on evidence published in peer-reviewed medical literature, technology assessments obtained from independent medical research organizations, evidence-based consensus statements and evidence-based guidelines from nationally recognized professional health care organizations.

Information about medical and pharmacy coverage policies can be found at by selecting "Medical and Pharmacy Coverage Policies" under "Resources." Policies can be reviewed by name or revision date. Users also may search for a particular policy using the search box. More detailed information can be found by reviewing "How to Read a Medical Coverage Policy" and "Understanding the Medical Coverage Policy Development Process" under “Helpful Links.”

Recent changes to medical and pharmacy coverage policies are listed below:

New pharmacy coverage policies

  • Erectile dysfunction medications
  • Ezetimibe (generic Zetia)
  • Glucagon-like peptide-1 (GLP-1) analogs
  • Lartruvo (olaratumab)
  • Soliqua 100/33 (insulin glargine and lixisenatide)
  • Topical metronidazole

New medical coverage policies

  • Carpal Tunnel Syndrome Surgical Treatments
  • Extended Ophthalmoscopy

Revised pharmacy coverage policies

  • Actemra (tocilizumab) intravenous
  • Actemra (tocilizumab) subcutaneous
  • Cimzia (certolizumab pegol)
  • Orencia (abatacept) subcutaneous
  • Sevelamer carbonate (generic Renvela)
  • Simponi (golimumab)

Revised medical coverage policies

  • Biofeedback
  • Colorectal Cancer Screening
  • Gene Expression Profiling
  • Hip, Knee and Shoulder Arthroscopic Surgeries
  • Nasal Surgical Treatments (Balloon Dilation and Endoscopic)
  • Noninvasive Prenatal Screening
  • Pharmacogenomics and Companion Diagnostics
  • Urinary and Fecal Incontinence Treatments